The society at a crossroads: Milestones and imperatives for cancer clinical trials

Academic Article


  • The Society of Surgical Oncology (SSO) has evolved into the leading academic oncologic society for surgeons. Major contributions by members of the SSO include significant participation in cancer clinical trials and basic biomedical research, which should be maintained and enhanced. Progress with outcomes research for basic, translational, and clinical investigations must be sustained with supportive biomedical technology to complete clinical trials in Phases I-IV. Investment in the development and support of translational researchers is of paramount importance to the future of the discipline. Published by Lippincott-Raven Publishers © 1997 The Society of Surgical Oncology, Inc.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Bland KI
  • Start Page

  • 523
  • End Page

  • 539
  • Volume

  • 4
  • Issue

  • 7